A randomized comparison of oral mifepristone to intravenous oxytocin for labor induction in women with prelabor rupture of membranes beyond 36 weeks' gestation

American Journal of Obstetrics and Gynecology

Volumn 192, Issue 2, 2005, Pages 445-451

  Wing, Deborah A ^a   Guberman, Cristiane ^a   Fassett, Michael ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Labor induction; Mifepristone; Prelabor rupture of membranes

Indexed keywords

MIFEPRISTONE; OXYTOCIN;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FETUS DISTRESS; GESTATIONAL AGE; HUMAN; LABOR INDUCTION; MEMBRANE RUPTURE; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; VAGINAL DELIVERY;

EID: 13444272083     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.07.058     Document Type: Article

References (34)

1. G.C. Gunn, D.R. Mishell Jr., and D.G. Morton Premature rupture of the fetal membranes: a review Am J Obstet Gynecol 106 1970 469 483
2. L.R. Lanier, R.W. Scarbrough Jr., D.W. Fillingim, and R.E. Baker Jr. Incidence of maternal and fetal complications associated with rupture of the membranes before onset of labor Am J Obstet Gynecol 93 1965 398 404
3. M.V. Wagner, C.P. Chin, C.J. Peters, B. Drexler, and L.A. Newman A comparison of early and delayed induction of labor with spontaneous rupture of membranes at term Obstet Gynecol 74 1989 93 97
4. J.M. Grant, E. Serle, T. Mahmood, P. Sarmandal, and D.I. Conway Management of prelabour rupture of the membranes in term primigravidae: report of a randomized prospective trial BJOG 99 1992 557 562
5. D.I. Conway, W.J. Prendiville, A. Morris, D.C. Speller, and G.M. Stirrat Management of spontaneous rupture of the membranes in the absence of labor in primigravid women at term Am J Obstet Gynecol 150 1984 947 951
6. P. Duff, R.W. Huff, and R.S. Gibbs Management of premature rupture of membranes and unfavorable cervix in term pregnancy Obstet Gynecol 63 1984 697 702
7. M.E. Hannah, A. Ohlsson, D. Farine, S.A. Hewson, E.D. Hodnett, and T.L. Myhr Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group N Engl J Med 334 1996 1005 1010
8. K. Goeschen Premature rupture of membranes near term: induction of labor with endocervical prostaglandin E2 gel or intravenous oxytocin Am J Perinatol 6 1989 181 184
9. G. Ekman-Ordeberg, N. Uldbjerg, and U. Ulmsten Comparison of intravenous oxytocin and vaginal prostaglandin E2 gel in women with unripe cervices and premature rupture of the membranes Obstet Gynecol 66 1985 307 310
10. A.L. Magos, M.C. Noble, A. Wong Ten Yuen, and C.H. Rodeck Controlled study comparing vaginal prostaglandin E2 pessaries with intravenous oxytocin for the stimulation of labour after spontaneous rupture of membranes BJOG 90 1983 726 731
11. L. Granstrom, G. Ekman, and U. Ulmsten Cervical priming and labor induction with vaginal application of 3 mg PGE2 in suppositories in term pregnant women with premature rupture of amniotic membranes and unfavorable cervix Acta Obstet Gynecol Scand 66 1987 429 431
12. D.A. Wing, and R.H. Paul Induction of labor with misoprostol for premature rupture of membranes beyond thirty-six weeks' gestation Am J Obstet Gynecol 179 1998 94 99
13. S.W. Ngai, W.K. To, T. Lao, and P.C. Ho Cervical priming with oral misoprostol in pre-labor rupture of the membranes at term Obstet Gynecol 87 1996 923 926
14. J.M. Crane, T. Delaney, and D. Hutchens Oral misoprostol for premature rupture of membranes at term Am J Obstet Gynecol 189 2003 720 724
15. E. Mozurkewich, J. Horrocks, S. Daley, P. Von Oeyen, M. Halvorson, and M. Johnson The MisoPROM Study: a multicenter randomized comparison of oral misoprostol and oxytocin for premature rupture of membranes at term Am J Obstet Gynecol 189 2003 1026 1030
16. K. Chwalisz, K. Stockemann, U. Fuhrmann, K.H. Fritzemeier, A. Einspanier, and R.E. Garfield Mechanism of action of antiprogestins in the pregnant uterus Ann N Y Acad Sci 761 1995 202 223
17. J.P. Neilson Mifepristone for induction of labour Cochrane Database Syst Rev 4 2000 CD002865
18. D.A. Wing, M.J. Fassett, and D.R. Mishell Mifepristone for preinduction cervical ripening beyond 41 weeks' gestation: a randomized controlled trial Obstet Gynecol 96 2000 543 548
19. R. Frydman, C. Lelaidier, C. Baton-Saint-Mleux, H. Fernandez, M. Vial, and P. Bourget Labor induction in women at term with mifepristone (RU 486): a double-blind, randomized, placebo-controlled study Obstet Gynecol 80 1992 972 975
20. C. Lelaidier, C. Baton, J.L. Benifla, H. Fernandez, P. Bourget, and R. Frydman Mifepristone for labour induction after previous cesarean section BJOG 101 1994 501 503
21. P.M. Stenlund, G. Ekman, A.R. Aedo, and M. Bygdeman Induction of labor with mifepristone - a randomized, double-blind study versus placebo Acta Obstet Gynecol Scand 78 1999 793 798
22. P.L. Giacalone, V. Targosz, F. Laffargue, G. Boog, and J.M. Faure Cervical ripening with mifepristone before labor induction: a randomized study Obstet Gynecol 92 1998 487 492
23. C.L. Elliott, J.E. Brennand, and A.A. Calder The effects of mifepristone on cervical ripening and labor induction in primigravidae Obstet Gynecol 92 1998 804 809
24. H. Su, E. Li, and L. Weng Mifepristone for induction of labor Chin J Obstet Gynecol 31 1996 676 680
25. [No author.] Electronic fetal heart rate monitoring: research guidelines for interpretation. National Institute of Child Health and Human Development Research Planning Workshop. Am J Obstet Gynecol 1997;177:1385-90.
26. R.A. Stookey, R.J. Sokol, and M.G. Rosen Abnormal contraction patterns in patients monitored in labor Obstet Gynecol 42 1973 359 367
27. American College of Obstetricians and Gynecologists, Committee on Obstetric Practice Prevention of early-onset group B streptococcal disease in newborns [Opinion 173] 1996 American College of Obstetricians and Gynecologists Washington, (DC)
28. S.J. Pocock When to stop a clinical trial BMJ 305 1992 235 240
29. D.G. Altman, K.F. Schulz, D. Moher, M. Egger, F. Davidoff, and D. Elbourne CONSORT GROUP (Consolidated Standards of Reporting Trials) The revised CONSORT statement for reporting randomized trials: explanation and elaboration Ann Intern Med 134 2001 663 694
30. G.J. Haluska, F.Z. Stanczyk, M.J. Cook, and M.J. Novy Temporal changes in uterine activity and prostaglandin response to RU486 in rhesus macaques in late gestation Am J Obstet Gynecol 157 1987 1487 1495
31. M.L. Swahn, and M. Bygdeman The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin BJOG 95 1988 126 134
32. M.W. Rodger, and D.T. Baird Pretreatment with mifepristone (RU 486) reduces the interval between prostaglandin administration and expulsion in second trimester abortion BJOG 97 1990 41 45
33. R. Frydman, H. Fernandez, J.C. Pons, and A. Ulmann Mifepristone (RU 486) and therapeutic late pregnancy termination: a double blind study of two different doses Hum Reprod 3 1988 803 806
34. N.C. Hill, M. Selinger, J. Ferguson, A. Lopez Bernal, and I.Z. MacKenzie The physiological and clinical effects of progesterone inhibition with mifepristone (RU 486) in the second trimester BJOG 97 1990 487 492